BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20427624)

  • 1. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
    Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
    Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dependence of IgG titers specific to various hepatitis C virus proteins on features of chronic infection course].
    Poponin DM; Gorovits ÉS; Bondarenko AL
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):57-61. PubMed ID: 22308730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
    Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
    Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment.
    Silva JPCG; Jesus LS; Isabel Schinoni M; Oliveira IS; Atta MLBS; Atta AM
    Int Immunopharmacol; 2021 Apr; 93():107405. PubMed ID: 33529909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to different virus antigens in patients with chronic hepatitis C].
    Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection].
    Iushchuk ND; Ogienko OL; Kruglov IV; Znoĭko OO; Braginskiĭ DM; Semiletov IuA; Finogenova MP; Alekseenkova TI; Ianina MV; Shibnev VA; Doroshenko NV
    Ter Arkh; 2002; 74(4):18-22. PubMed ID: 12043232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant antibodies specific for hepatitis C virus core and envelope E2 peptides from an immune phage display library.
    Chan SW; Bye JM; Jackson P; Allain JP
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2531-9. PubMed ID: 8887487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
    Encke J; zu Putlitz J; Geissler M; Wands JR
    J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.
    Pereboeva LA; Pereboev AV; Morris GE
    J Med Virol; 1998 Oct; 56(2):105-11. PubMed ID: 9746064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of antibodies against core, NS3, NS4, NS5 region of hepatitis C virus in patients with hepatitis C].
    Ishii K; Ishibashi M; Ohtake T; Kano S; Saito H; Watanabe K
    Rinsho Byori; 1997 Dec; 45(12):1156-62. PubMed ID: 9437896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
    Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
    Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
    Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
    J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis.
    Rosa C; Osborne S; Garetto F; Griva S; Rivella A; Calabresi G; Guaschino R; Bonelli F
    J Virol Methods; 1995 Oct; 55(2):219-32. PubMed ID: 8537460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
    Ferns RB; Tuke PW; Sweenie CH
    J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited humoral immunity in hepatitis C virus infection.
    Chen M; Sällberg M; Sönnerborg A; Weiland O; Mattsson L; Jin L; Birkett A; Peterson D; Milich DR
    Gastroenterology; 1999 Jan; 116(1):135-43. PubMed ID: 9869611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.